Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Accumulated Depreciation: 2020-2022

Historic Accumulated Depreciation for Terns Pharmaceuticals (TERN) over the last 3 years, with Dec 2022 value amounting to $1.4 million.

  • Terns Pharmaceuticals' Accumulated Depreciation rose 18.31% to $1.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $1.4 million, marking a year-over-year increase of 18.31%. This contributed to the annual value of $1.4 million for FY2022, which is 18.31% up from last year.
  • According to the latest figures from FY2022, Terns Pharmaceuticals' Accumulated Depreciation is $1.4 million, which was up 18.31% from $1.2 million recorded in FY2021.
  • Terns Pharmaceuticals' Accumulated Depreciation's 5-year high stood at $1.4 million during FY2022, with a 5-year trough of $689,000 in FY2020.
  • Moreover, its 3-year median value for Accumulated Depreciation was $1.2 million (2021), whereas its average is $1.1 million.
  • Data for Terns Pharmaceuticals' Accumulated Depreciation shows a peak YoY surged of 71.99% (in 2021) over the last 5 years.
  • Yearly analysis of 3 years shows Terns Pharmaceuticals' Accumulated Depreciation stood at $689,000 in 2020, then surged by 71.99% to $1.2 million in 2021, then climbed by 18.31% to $1.4 million in 2022.